SCHEMBL4803397

SCHEMBL4803397

CCCCCCCCCCCCCCCC(=O)N=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.56
CES1 P23141 4/20 0.56
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 7/20 0.54
PPARD Q03181 7/20 0.54
PPARA Q07869 7/20 0.54
HDAC11 Q96DB2 5/20 0.54
TSHR P16473 5/20 0.54
PTPN1 P18031 3/20 0.54
ALDH1A1 P00352 3/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54
ALOX15 P16050 1/20 0.54
PDE4A P27815 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5127510 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL1365133 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL25526352 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL13903246 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL5126821 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL1257720 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL4802270 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL1367103 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL20648076 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD
SCHEMBL2401194 1.00 CES2 (0.56) CES2CES1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2575444-B1 DILUTABLE BIOCIDAL COMPOSITIONS AND METHODS OF USE STEPAN CO (US) 2017-05-10 EP claimed
CN-103857290-A Sporicidal formulation including amine oxide surfactant and a mixture of oxidants KIMBERLY CLARK CO 2014-06-11 CN claimed
US-8609149-B2 Dilutable biocidal compositions and methods of use STEPAN COMPANY (US) 2013-12-17 US claimed
US-20130101677-A1 Dilutable Biocidal Compositions and Methods of Use STEPAN COMPANY (US) 2013-04-25 US claimed
EP-2575444-A1 DILUTABLE BIOCIDAL COMPOSITIONS AND METHODS OF USE Stepan Company (US) 2013-04-10 EP claimed
CN-101636143-A Compositions comprising amine oxide surfactants or soil penetrants PROCTER & GAMBLE 2010-01-27 CN claimed
CN-119744164-A Odor and colorant stable compositions 西姆莱斯股份公司 2025-04-01 CN disclosed
CN-119604270-A Comprising an antimicrobial agent accelerator composition 西姆莱斯股份公司 2025-03-11 CN disclosed
CN-114728092-B Edge block with improved odor performance 西姆莱斯股份公司 2025-02-28 CN disclosed
CN-118829416-A Composition (III) 西姆莱斯股份公司 2024-10-22 CN disclosed
CN-118159632-A Perfume and perfume mixture 西姆莱斯股份公司 2024-06-07 CN disclosed
CN-116284893-A Defect two-dimensional nanomaterial modified atomic oxygen resistant composite film and preparation method thereof 兰州大学 2023-06-23 CN disclosed
CN-114727914-A Product for the indirect transfer of a cosmetic active to the skin 西姆莱斯股份公司 2022-07-08 CN disclosed
CN-101636143-A Compositions comprising amine oxide surfactants or soil penetrants PROCTER & GAMBLE 2010-01-27 CN disclosed
CN-101516323-A Oral compositions comprising gel networks PROCTER & GAMBLE (US) 2009-08-26 CN disclosed
CN-101422148-A Composition and method for treating plants with exogenous chemicals MONSANTO TECHNOLOGY LLC (US) 2009-05-06 CN disclosed
CN-101267796-A Shampoo comprising a gel network PROCTER & GAMBLE (US) 2008-09-17 CN disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR CES2 547/4885CES1 1963/4885GPR84 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.